Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation

To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Meta-analysis comparing study effects using four summary estimates. Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Judith Prochaska, PhD, MPH, is Associate Professor in the Department of Medicine at Stanford University with the Stanford Prevention Research Center.

Publication

 

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
You have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today. Subscribe for unlimited access.
Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×